CFN Media TV

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Toronto, Ontario–(Newsfile Corp. – April 16, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)…

Aduro Clean Technologies Reports Third Quarter Fiscal 2025 Results

LONDON, Ontario, April 15, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or…

From $1 to $8? Why Analyst Experts Are Bullish on Cardiol

Sometimes stock market performance doesn’t line up with the fundamentals of a…